Teleflex Inc. (NYSE:TFX) hit a new 52-week high on Friday . The stock traded as high as $181.62 and last traded at $181.27, with a volume of 85,336 shares trading hands. The stock had previously closed at $179.14.

TFX has been the subject of several recent research reports. Barclays PLC reissued an “overweight” rating and issued a $183.00 price target (up previously from $170.00) on shares of Teleflex in a research note on Tuesday, June 14th. Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research report on Wednesday, April 20th. Deutsche Bank AG restated a “buy” rating on shares of Teleflex in a research report on Monday, March 14th. Leerink Swann upped their target price on Teleflex from $153.00 to $171.00 and gave the company a “market perform” rating in a research report on Monday, May 2nd. Finally, Raymond James Financial Inc. upgraded Teleflex from an “outperform” rating to a “strong-buy” rating in a research report on Wednesday, June 1st. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $165.11.

The stock has a 50-day moving average of $170.24 and a 200 day moving average of $151.60. The stock has a market cap of $7.94 billion and a price-to-earnings ratio of 34.29.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, April 28th. The medical technology company reported $1.52 EPS for the quarter, topping the Zacks’ consensus estimate of $1.35 by $0.17. The company had revenue of $424.90 million for the quarter, compared to analysts’ expectations of $425.37 million. The business’s revenue was down 1.0% compared to the same quarter last year. During the same period last year, the business posted $1.30 earnings per share. Equities research analysts expect that Teleflex Inc. will post $7.24 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 15th. Stockholders of record on Monday, May 16th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date of this dividend was Thursday, May 12th.

In other news, Director Stuart A. Randle sold 797 shares of the firm’s stock in a transaction that occurred on Monday, June 6th. The shares were sold at an average price of $166.10, for a total transaction of $132,381.70. Following the transaction, the director now directly owns 4,592 shares of the company’s stock, valued at $762,731.20. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Thomas Anthony Kennedy sold 15,102 shares of the firm’s stock in a transaction that occurred on Monday, May 16th. The stock was sold at an average price of $160.20, for a total transaction of $2,419,340.40. Following the transaction, the vice president now directly owns 6,990 shares in the company, valued at $1,119,798. The disclosure for this sale can be found here.

Other institutional investors recently modified their holdings of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Teleflex by 0.4% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,062 shares of the medical technology company’s stock worth $1,586,000 after buying an additional 53 shares during the period. State Board of Administration of Florida Retirement System raised its position in shares of Teleflex by 1.1% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 45,309 shares of the medical technology company’s stock worth $5,956,000 after buying an additional 486 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Teleflex by 2.1% in the fourth quarter. PNC Financial Services Group Inc. now owns 30,825 shares of the medical technology company’s stock worth $4,054,000 after buying an additional 623 shares during the period. Retirement Systems of Alabama raised its position in shares of Teleflex by 1.3% in the fourth quarter. Retirement Systems of Alabama now owns 53,457 shares of the medical technology company’s stock worth $7,027,000 after buying an additional 703 shares during the period. Finally, Mastrapasqua Asset Management Inc. raised its position in shares of Teleflex by 9.8% in the fourth quarter. Mastrapasqua Asset Management Inc. now owns 10,305 shares of the medical technology company’s stock worth $1,355,000 after buying an additional 920 shares during the period.

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company also markets and sells its products to hospitals and healthcare providers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.